Stanford University
Showing 4,691-4,700 of 7,810 Results
-
Alicia Mirza
Clinical Assistant Professor, Medicine - Pulmonary, Allergy & Critical Care Medicine
BioDr. Alicia Mirza is quadruple board-certified in Internal Medicine, Pediatrics, Pulmonary Medicine, and Critical Care Medicine. She is now an Assistant Professor in the Division of Pulmonary, Allergy, and Critical Care Medicine (PACCM) at Stanford, where she serves as Associate Director of the Adult Cystic Fibrosis (CF) Program.
She has expertise across a breadth of pulmonary and intensive care domains, with her clinical and research interests centering on CF and bronchiectasis. She is a CF Foundation (CFF) Program for Adult Care Excellence grant awardee. She has worked on quality improvement projects in adult CF care, including initiatives in advanced care planning, pediatric to adult transitions, primary care utilization, and remote monitoring. She is involved in clinical trials as well as registry-based research in both CF and non-CF bronchiectasis.
Nationally, Dr. Mirza was elected to the CHEST Bronchiectasis Network, where she collaborates with experts across the country to expand education in bronchiectasis through podcasts, training modules, and lectures. An active educator, Dr. Mirza teaches Stanford medical students, residents, and fellows. She is engaged both locally and internationally through conference presentations at CHEST, California Thoracic Society, and the North American CF Conference.
She also serves as Co-director of Wellbeing for Stanford PACCM, where she is committed to advancing faculty wellness and fostering a culture of professional fulfillment. In both her clinical and academic work, she emphasizes a holistic approach to supporting patients and colleagues alike, with attention to the whole person and the systems that sustain their health and wellbeing. -
Paul Salomon Mischel
Fortinet Founders Professor and Professor, by courtesy, of Neurosurgery
Current Research and Scholarly InterestsMy research bridges cancer genetics, signal transduction and cellular metabolism as we aim to understand the molecular mechanisms that drive cancer development, progression, and drug resistance. We have made a series of discoveries that have identified a central role for ecDNA (extrachromosomal DNA) in cancer development, progression, accelerated tumor evolution and drug resistance.
-
Kavita Mishra
Clinical Associate Professor, Obstetrics & Gynecology
BioDr. Kavita Mishra is a board-certified urogynecologist who specializes in transgender surgery and the treatment of pelvic floor disorders. She has specific training in gender-affirming vaginoplasty, pelvic organ prolapse, and urinary and fecal incontinence. She has expertise in vaginal and minimally invasive reconstructive pelvic surgery, including laparoscopic and robotic approaches.
-
Maneesh Kumar Misra
Clinical Associate Professor, Pathology
Current Research and Scholarly InterestsMy research goal is to utilize the cutting edge of stat of art histocompatibility testing to better understand the humoral and cellular responses in clinical transplantation, and to translate this knowledge into improved treatment, and transplant outcome.
-
Tsuyoshi (Yoshi) Mitarai
Clinical Professor, Emergency Medicine
Current Research and Scholarly InterestsCritical Care, optimal resource allocations for inpatient care
-
William Mitch
Professor of Civil and Environmental Engineering
BioBill Mitch received a B.A. in Anthropology (Archaeology) from Harvard University in 1993. During his studies, he excavated at Mayan sites in Belize and surveyed sites dating from 2,000 B.C. in Louisiana. He switched fields by receiving a M.S. degree in Civil and Environmental Engineering at UC Berkeley. He worked for 3 years in environmental consulting, receiving his P.E. license in Civil Engineering in California. Returning to UC Berkeley in 2000, he received his PhD in Civil and Environmental Engineering in 2003. He moved to Yale as an assistant professor after graduation. His dissertation received the AEESP Outstanding Doctoral Dissertation Award in 2004. At Yale, he serves as the faculty advisor for the Yale Student Chapter of Engineers without Borders. In 2007, he won a NSF CAREER Award. He moved to Stanford University as an associate professor in 2013.
Employing a fundamental understanding of organic chemical reaction pathways, his research explores links between public health, engineering and sustainability. Topics of current interest include:
Public Health and Emerging Carcinogens: Recent changes to the disinfection processes fundamental to drinking and recreational water safety are creating a host of highly toxic byproducts linked to bladder cancer. We seek to understand how these compounds form so we can adjust the disinfection process to prevent their formation.
Global Warming and Oceanography: Oceanic dissolved organic matter is an important global carbon component, and has important impacts on the net flux of CO2 between the ocean and atmosphere. We seek to understand some of the important abiotic chemical reaction pathways responsible for carbon turnover.
Sustainability and Persistent Organic Pollutants (POPs): While PCBs have been banned in the US, we continue to produce a host of structurally similar chemicals. We seem to understand important chemical pathways responsible for POP destruction in the environment, so we can design less persistent and problematic chemicals in the future.
Engineering for Sustainable Wastewater Recycling: The shortage of clean water represents a critical challenge for the next century, and has necessitated the recycling of wastewater. We seek to understand ways of engineer this process in ways to minimize harmful byproduct formation.
Carbon Sequestration: We are evaluating the formation of nitrosamine and nitraminecarcinogens from amine-based carbon capture, as well as techniques to destroy any of these byproducts that form. -
Beverly S. Mitchell, M.D.
George E. Becker Professor of Medicine, Emerita
Current Research and Scholarly InterestsBeverly Mitchell's research relates to the development of new therapies for hematologic malignancies, including leukemias and myelodsyplastic syndromes. She is interested in preclinical proof of principle studies on mechanisms inducing cell death and on metabolic targets involving nucleic acid biosynthesis in malignant cells. She is also interested in the translation of these studies into clinical trials.
